Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michaela Luthman"'
Autor:
Anja Porwit-MacDonald, Gunnar Grimfors, Jan Samuelsson, Inger Marie S. Dahl, Olle Linder, Michaela Luthman, Ingemar Winquist, Eva Hellström-Lindberg, Greger Lindberg, Anders Rådlund, Eva Hesse-Sundin, Martin Hjorth, Finn Wisløff, Nina Gulbrandsen, Gunnar Öberg, Tomas Ahlgren, Jon Magnus Tangen, Ingunn Dybedal, Eva Löfvenberg, Lena Kanter-Lewensohn
Publikováno v:
British Journal of Haematology. 120:1037-1046
We have published previously a prototype of a decision model for anaemic patients with myelodysplastic syndromes (MDS), in which transfusion need and serum erythropoietin (S-Epo) were used to define three groups with different probabilities of erythr
Autor:
Inger Marie S. Dahl, Olle Linder, Yves Beguin, Magnus Carlsson, Jan Carneskog, Ingemar Winqvist, Herman Nilsson-Ehle, Eva Hellström-Lindberg, Michaela Luthman, Lena Kanter-Lewensohn, Åke Öst, Ingunn Dybedal, Jon-Magnus Tangen, Eva Löfvenberg, Jan Samuelsson, Anders Österborg, Gunnar Öberg, Gunnar Grimfors, Tomas Ahlgren
Publikováno v:
Blood. 92:68-75
Treatment with erythropoietin (epo) may improve the anemia of myelodysplastic syndromes (MDS) in approximately 20% of patients. Previous studies have suggested that treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and e
Autor:
Viktoria Hjalmar, Jeanette Lundin, Magnus Björkholm, Ulf Tidefelt, Mats Merup, Håkan Mellstedt, Bo Björkstrand, Michaela Luthman, Olle Linder, Fredrik Celsing, Anders Österborg
Publikováno v:
The hematology journal : the official journal of the European Haematology Association. 4(4)
Cyclophosphamide, interferon-a and betamethasone are all effective agents for the treatment of multiple myeloma (MM) with different mechanisms of action. The clinical effect of a combination of cyclophosphamide 725 mg/m 2 i.v. days 1 and 3, interfero
Autor:
Eva, Hellström-Lindberg, Nina, Gulbrandsen, Greger, Lindberg, Tomas, Ahlgren, Inger Marie S, Dahl, Ingunn, Dybedal, Gunnar, Grimfors, Eva, Hesse-Sundin, Martin, Hjorth, Lena, Kanter-Lewensohn, Olle, Linder, Michaela, Luthman, Eva, Löfvenberg, Gunnar, Oberg, Anja, Porwit-MacDonald, Anders, Rådlund, Jan, Samuelsson, Jon Magnus, Tangen, Ingemar, Winquist, Finn, Wisloff
Publikováno v:
British journal of haematology. 120(6)
We have published previously a prototype of a decision model for anaemic patients with myelodysplastic syndromes (MDS), in which transfusion need and serum erythropoietin (S-Epo) were used to define three groups with different probabilities of erythr